Curtis Layton is the CEO and Co-Founder of Protillion Biosciences, a company founded on technology he co-invented at Stanford. With a Ph. D. in Biochemistry from Duke University, he is an expert in therapeutic protein discovery, using proprietary AI and high-throughput technologies to engineer next-generation protein therapeutics.
His interests lie at the intersection of technology and biology, following advancements in adjacent fields like clinical genomics and personalized medicine. He actively engages with his professional network to discuss and promote innovation within the broader biotech landscape, showing a deep passion for the industrys future.
His companys technology can identify tens of thousands of pH-dependent antibody binders in a single run.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.